PREVALENCE OF BETA-THALASSEMIA TRAIT IN QUETTA CITY, CROSS SECTION STUDY (original) (raw)

Abstract

ABSTRACT: Identifying the prevalence of Beta Thalassaemia and its carriers in the population of Quetta city . METHOD: Rapid methods of screening like Osmotic Fragility T est (OFT),Mean Cell Volume(MCV), Mean Cell Hemoglobin(MCH), Red Blood Cell (RBC) count and Hemoglobin (Hb) estimation was performed on hematology analyzer , For discrimination Shine and Lal formula was used and morphology of erythrocytes were studied. For these fresh venous blood samples were obtained from different blood banks and hospitals of Quetta city . Using cross section method, a total of 570 blood samples were obtained, Among those 59% were male and 41 % were female. RESULT: Prevalence of Beta thalassemia in population of the city was 6.5% in 2012. The median age was 20 years. 72% were male and 27% were females victims. Ethnic group distribution Pathans, Baloch, Hazara, Afghan refugees and miscellaneous were 41%, 30%, 5%, 11% and 14% respectively . Hematological parameters, OFT observation, blood become turbid in all cases, the mean Hb level were not too much high i.e 10.2 g/dl , MCH (mean) was 18.2(pg) , RBC count 5.9 6 (10 /L) mean, MCV was 56(fl) ,In microscopic examination, erythrocytes contained high numbers of microcytosis. RBC morphology also show basophilic stippling and hypochromic. CONCLUSION: OFT not statistically tested for discriminating between anemia, Iron deficiency and Beta thalassemia. Due to absence of a single pathognomonic findings that covers all variants there is need of a set of analysis parameter which give reliable and quick results. On the basis of the evidence provided there is a need for immediately implementing proper screening at grass root level as per guidelines issued by the WHO. Further there is the need of law implemented for couples before they are given approval to get married.

Figures (5)

Key takeaways

sparkles

AI

  1. Beta thalassemia prevalence in Quetta city was found to be 6.5% among 570 samples in 2012.
  2. Demographic distribution shows 72% of affected individuals were male, with ethnic prevalence varying significantly.
  3. Utilized rapid screening methods include Osmotic Fragility Test (OFT), Mean Cell Volume (MCV), and Red Blood Cell count.
  4. Study emphasizes the urgent need for systematic screening and legal measures for premarital testing in Pakistan.
  5. Findings suggest that existing screening methods require standardization for accuracy and reliability.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (27)

  1. Betty Ciesla (2007). Hematology in Practice. Pub by F. A. Davis Company. Philadelphia 79.
  2. Barbara J Bain (2006). Blood cells, A th practical guide. 4 Ed. Blackwell Pub Uk.
  3. David J. Weatherall, J. B. Clegg (2008). The Thalassaemia Syndromes. John Wiley & Sons published by Blackwell science Ltd USA. 13.
  4. Jason Chow, Lorraine Phelan, and Barbara J. Bain (2005). Evaluation of Single Tube Osmotic Fragility as a Screening Test for T h a l a s s e m i a . A m e r i c a n J o u r n a l o f Hematology 79:198-201.
  5. Thool AA, Walde MS, Shrikhande AV, Talib VH.(1998). A simple screening test for heterozygous beta thalassemia. Indian J Pathol Microbiol. 41:423 vol 6.
  6. GeoNames geographical database (2013) Switzerland.
  7. n . Manybooks.net. 2010. Story about Chiltan Mount a frugal pair.
  8. Blood, Peter, ed.(1995). Baloch Pakistan, A Country Study. Washington: GPO for the Library of Congress.
  9. John Old, J. Traeger-Synodinos, R. Galanello, M. Petrou and M. Angastiniotis (2004). Prevention of Thalassaemias and o t h e r h a e m o g l o b i n d i s o r d e r s Vo l 2 ( L a b o ra t o r y M e t h o d s ) . P u b l i s h e d b y Thalassaemia International Federation, Cyprus.
  10. Afroz M, Shamsi TS and Syed S (1998). Predictive value of MCV/RBC count ratio to discriminate between iron deficiency anaemia and beta thalassaemia trait. J Pak Med Assoc.48.1:18-9.
  11. England JM, Fraser PM (1973). Differentiation of iron deficiency from thalassemia trait by routine blood count Lancet. 449-52.
  12. st Ayesha abid. (2003).Blood physiology 1 Ed. Multi color pub. Lahore.
  13. Koolman,K.H.Roeham. (2005). Color Atlas of Biochemistry, pg 281. 2nd edition .Thieme Stuttgart pub. New york.
  14. Joishy SK, Shafer JA and Rowley PT.(1986). The contribution of red cell morphology to the diagnosis of beta-thalassemia trait. Blood Cells.11(3):367-7.
  15. Walford DM, Deacon R (1976) α thalassemia trait in various racial groups in the United Kingdom: characterization of a variant of alpha thalassemia in Indians, Br J Haematol, vol. 34, 193-206.
  16. H e n n e ke n s C H , B u r i n g J E . ( 1 9 8 7 ) . Epidemiology in Medicine, Lippincott Williams & Wilkins.
  17. Mennuti MT. (2008). Genetic screening in reproductive health care. Clin Obstet Gynecol.51:3-23.
  18. AlHamdan NA, AlMazrou YY, Al Swaidi FM, et al (2007). Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in Medicine. 9:372-377.
  19. Ghotbi N, Tsukatani T (2005). Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran. La Revue de Sante de la Mediterranee orientale.11:308-31.
  20. Chenwang, L.BEGANYI, Benrnardj and Fernandes(2000 ).Measurements of Red Cell Parameters in α-Thalassemia Trait, Correlation With the Genotype. laboratory Hematology 6:163-166.
  21. Shine I, Lal S.(1977) A strategy to detect beta-thalassaemia minor: Lancet. 692.
  22. Zahid hussain, Naumaan M and S.chughtai.(2005). Diagnostic significance of red cell indices in beta-thalassaemia Triat. BIOMEDICA VOL. 21.
  23. Srivastava PC(1973).Differentiation of thalassaemia minor from iron deficiency Lancet .154-55.
  24. Z. Binbay, B.T. Lal, M. Solmaz,Y. Albayrak, S. Sagir (2013). Depression in mothers of children with thalassemia. European Psychiatry, , Supplement 1, Vol 28 1.
  25. Pranee Winichagoona, R.Kumbunluea, P.Sirankapracha et al (2015). Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy. Blood Cells, Molecules, and Diseases.
  26. K. M. Musallam, Ali T. Taher, M. Karimi, E. A. Rachmilewitz (2012). Cerebral infarction in β-thalassemia intermedia: Breaking the silence. Thrombosis Research, Vol 130, Issue 5, 695-702.
  27. JUMDC Vol. 6, Issue 4, October-December 2015